PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis

TSX-V:PINK • CA71385D1078

0.29 CAD
+0.01 (+3.57%)
Last: Feb 19, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall PINK gets a fundamental rating of 3 out of 10. We evaluated PINK against 15 industry peers in the Health Care Equipment & Supplies industry. PINK may be in some trouble as it scores bad on both profitability and health. PINK is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year PINK has reported negative net income.
  • PINK had a negative operating cash flow in the past year.
  • In the past 5 years PINK always reported negative net income.
  • PINK had a negative operating cash flow in each of the past 5 years.
PINK.CA Yearly Net Income VS EBIT VS OCF VS FCFPINK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • PINK's Return On Assets of -239.48% is in line compared to the rest of the industry. PINK outperforms 53.33% of its industry peers.
  • With a Return On Equity value of -412.07%, PINK perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -239.48%
ROE -412.07%
ROIC N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
PINK.CA Yearly ROA, ROE, ROICPINK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • PINK has a Gross Margin (59.01%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of PINK has grown nicely.
  • The Profit Margin and Operating Margin are not available for PINK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
PINK.CA Yearly Profit, Operating, Gross MarginsPINK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PINK has more shares outstanding
  • PINK has more shares outstanding than it did 5 years ago.
  • PINK has a worse debt/assets ratio than last year.
PINK.CA Yearly Shares OutstandingPINK.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PINK.CA Yearly Total Debt VS Total AssetsPINK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • PINK has an Altman-Z score of -24.33. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -24.33, PINK perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
  • PINK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • PINK has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. PINK outperforms 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -24.33
ROIC/WACCN/A
WACC9.32%
PINK.CA Yearly LT Debt VS Equity VS FCFPINK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • PINK has a Current Ratio of 1.21. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
  • PINK's Current ratio of 1.21 is fine compared to the rest of the industry. PINK outperforms 80.00% of its industry peers.
  • PINK has a Quick Ratio of 1.17. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
  • PINK's Quick ratio of 1.17 is amongst the best of the industry. PINK outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.17
PINK.CA Yearly Current Assets VS Current LiabilitesPINK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • PINK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.89%, which is quite impressive.
  • Looking at the last year, PINK shows a very strong growth in Revenue. The Revenue has grown by 201.31%.
  • The Revenue has been growing by 354.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)36.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.95%
Revenue 1Y (TTM)201.31%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%259.88%

3.2 Future

  • Based on estimates for the next years, PINK will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.78% on average per year.
  • Based on estimates for the next years, PINK will show a very strong growth in Revenue. The Revenue will grow by 120.05% on average per year.
EPS Next Y21.56%
EPS Next 2Y17.25%
EPS Next 3Y18.41%
EPS Next 5Y18.78%
Revenue Next Year244.83%
Revenue Next 2Y205.13%
Revenue Next 3Y171.19%
Revenue Next 5Y120.05%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PINK.CA Yearly Revenue VS EstimatesPINK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
PINK.CA Yearly EPS VS EstimatesPINK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PINK.CA Price Earnings VS Forward Price EarningsPINK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PINK.CA Per share dataPINK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • PINK's earnings are expected to grow with 18.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.25%
EPS Next 3Y18.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PINK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (2/19/2026, 7:00:00 PM)

0.29

+0.01 (+3.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-24
Inst Owners22.19%
Inst Owner ChangeN/A
Ins Owners21.86%
Ins Owner ChangeN/A
Market Cap38.02M
Revenue(TTM)1.89M
Net Income(TTM)-14.35M
Analysts80
Price Target1.89 (551.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.13%
Min EPS beat(2)22.11%
Max EPS beat(2)28.15%
EPS beat(4)2
Avg EPS beat(4)-8.72%
Min EPS beat(4)-66.34%
Max EPS beat(4)28.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-36.12%
Min Revenue beat(2)-40.14%
Max Revenue beat(2)-32.1%
Revenue beat(4)2
Avg Revenue beat(4)22.41%
Min Revenue beat(4)-40.14%
Max Revenue beat(4)160.4%
Revenue beat(8)4
Avg Revenue beat(8)6.12%
Revenue beat(12)5
Avg Revenue beat(12)-5.78%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.78
P/FCF N/A
P/OCF N/A
P/B 8
P/tB 8
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.02
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -239.48%
ROE -412.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.01%
FCFM N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.17
Altman-Z -24.33
F-Score2
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.95%
EPS Next Y21.56%
EPS Next 2Y17.25%
EPS Next 3Y18.41%
EPS Next 5Y18.78%
Revenue 1Y (TTM)201.31%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%259.88%
Revenue Next Year244.83%
Revenue Next 2Y205.13%
Revenue Next 3Y171.19%
Revenue Next 5Y120.05%
EBIT growth 1Y20.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.31%
EBIT Next 3Y15.32%
EBIT Next 5Y24.37%
FCF growth 1Y-35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.75%
OCF growth 3YN/A
OCF growth 5YN/A

PERIMETER MEDICAL IMAGING AI / PINK.CA FAQ

What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PINK.CA.


Can you provide the valuation status for PERIMETER MEDICAL IMAGING AI?

ChartMill assigns a valuation rating of 0 / 10 to PERIMETER MEDICAL IMAGING AI (PINK.CA). This can be considered as Overvalued.


Can you provide the profitability details for PERIMETER MEDICAL IMAGING AI?

PERIMETER MEDICAL IMAGING AI (PINK.CA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for PERIMETER MEDICAL IMAGING AI?

The Earnings per Share (EPS) of PERIMETER MEDICAL IMAGING AI (PINK.CA) is expected to grow by 21.56% in the next year.